Prosecution Insights
Last updated: April 19, 2026

Lathrop Gpm LLP

166 pending office actions • 124 clients

Portfolio Summary

166
Total Pending OAs
43
Final Rejections
123
Non-Final OAs

Client Portfolio (124 clients)

Client (Assignee)Pending OAs
UNIVERSITY OF MASSACHUSETTS 8
DH TECHNOLOGIES DEVELOPMENT PTE. LTD. 5
DH TECHNOLOGIES DEVELOPMENT PTE. LTD. 5
Scpharmaceuticals Inc. 3
Waabi Innovation Inc. 3
Pathios Therapeutics Limited 3
On Target Laboratories, LLC 3
Astrin Biosciences, Inc. 3
Flanders Electric Motor Service, LLC 2
Wageningen Universiteit 2
Waabi Innovation Inc. 2
Ideaya Biosciences, Inc. 2
Kyushu University, National University Corporation 2
Intabio, LLC 2
UNIVERSITAET ULM 2
Mendus B.V. 2
Massachusetts Institute Of Technology 2
National University Corporation Shiga University Of Medical Science 2
Intabio, LLC 2
Korea Institute Of Radiological & Medical Sciences 2
Spheritech Ltd. 2
Momtech, Inc. 1
Filamon Ltd. 1
Global Life Sciences Solutions UK Limited 1
Flanders Electric Motor Service, LLC 1
Sequelae, Inc. 1
TransforML Platforms Inc. 1
Eku Power Drives Inc. 1
Total Safety U.S., Inc. 1
Columbia Insurance Company 1
Covalon Technologies, Ltd. 1
Coroos Beheer BV 1
K-Orbital LLC 1
Bluescope Buildings North America 1
Zhejiang Beihuan Outdoor Products Co., Ltd. 1
The Akkermansia Company 1
Ikaria Inc. 1
Whiskers Worldwide, LLC 1
National University Of Singapore 1
Monash University 1
Mycocycle, Inc. 1
Alkermes Pharma Ireland Limited 1
The Board Of Trustees Of The University Of Illinois 1
Genmab A/S 1
Orbiotek Sàrl 1
The Governing Council of the University of Toronto 1
Kinaset Therapeutics, Inc. 1
Glaxosmithkline Intellectual Property (No.4) Limited 1
Pormedtec Co., Ltd. 1
Shenzhen Bao'An People'S Hospital 1
Leap Of Faith Technologies, Inc. 1
The Governors of the University of Alberta 1
Mendus B.V. 1
Mass Luminosity, Inc. 1
Rockefeller University 1
Pfizer, Inc. 1
Simon Fraser University 1
COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES 1
Kymab Limited 1
Fondazione Istituto Italiano Di Tecnologia 1
BIOAGE LABS, INC. 1
James Cook University 1
The Heart Research Institute Ltd. 1
Fondazione Per La Ricerca Sulla Fibrosi Cistica Ets 1
4D Vision Corp. 1
AusMed Global Limited 1
Niigata University 1
Rege Nephro Co., Ltd. 1
All Flex Solutions, Inc. 1
Kawasaki Institute Of Industrial Promotion 1
Université De Lausanne 1
Mushlabs GmbH 1
Visionaire Products, Inc. 1
Global Life Sciences Solutions Canada Ulc 1
Msd International GmbH 1
F. Hoffmann-La Roche AG 1
Cardiovascular Lab S.r.l. 1
BEIJING IMMUNOAH PHARMATECH CO., LTD. 1
Chemical & Biopharmaceutical Laboratories Of Patras S.A. 1
Mayo Foundation for Medical Education and Research 1
The University of Tokyo 1
Als Therapy Development Institute 1
Theramex Hq UK Limited 1
University Of Sydney 1
Ben Prince 1
Servier Pharmaceuticals Llc. 1
UNIVERSITA' DEGLI STUDI DEL PIEMONTE ORIENTALE "A. AVOGADRO" 1
Kantonsspital St. Gallen 1
Anagenix IP Limited 1
Transine Therapeutics Limited 1
Alkermes Pharma Ireland Limited 1
Rousselot BV 1
The Board Of Trustees Of The University Of Illinois 1
Dragonfly Therapeutics, Inc. 1
Mimetas B.V. 1
Grey Wolf Therapeutics Limited 1
Compagnie Gervais Danone 1
GE Healthcare AS 1
Ender Holding AG 1
Astrin Biosciences, Inc. 1
UNIVERSITAET ZUERICH 1
UNIVERSITAET ZUERICH 1
Nutcracker Therapeutics, Inc. 1
The University of Sydney 1
I2O Therapeutics, Inc. 1
Nippon Chemiphar Co., Ltd. 1
Tatsuya Sawamura 1
Freshpoint Quality Assurance Ltd. 1
Yeda Research And Development Co. Ltd. 1
Almac Discovery Limited 1
BIONTECH SE 1
GE Healthcare AS 1
Cullinan Therapeutics, Inc. 1
Somar Corporation 1
VICO Therapeutics B.V. 1
Nihon Medi-Physics Co., Ltd. 1
Nido Biosciences, Inc. 1
Hunan Warrant Pharmaceutical Technology Development Co., Ltd. 1
The General Hospital Corporation 1
Scuola Internazionale Superiore Studi Internazionale Superiore Di Studi Avanzati - Sissa 1
The Regents of the University of California 1
BIODESIX, INC. 1
Noria Therapeutics, Inc. 1
Keio University 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19360165 Untitled Momtech, Inc. WEAVER, SUE A 3733 Non-Final OA
19306947 Untitled Flanders Electric Motor Service, LLC PATEL, NEEL G 3676 Non-Final OA
19355164 EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS Filamon Ltd. ESPINOSA, CLAUDIA EDILMA 1654 Non-Final OA Oct 10, 2025
19337639 METHOD FOR PRODUCING A LIQUID COMPOSITION INCLUDING A NANOPARTICLE, AND FORMULATION THEREOF Global Life Sciences Solutions UK Limited PHAN, DOAN THI-THUC 1613 Non-Final OA Sep 23, 2025
19287736 ADAPTIVE AUTO-DRILLING FOR DRILLING APPLICATIONS Flanders Electric Motor Service, LLC WLODARSKI, NICHOLAS NMN 3672 Non-Final OA Jul 31, 2025
19271284 PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE Scpharmaceuticals Inc. HUANG, GIGI GEORGIANA 1613 Non-Final OA Jul 16, 2025
19224021 USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS Wageningen Universiteit GOUGH, TIFFANY MAUREEN 1651 Non-Final OA May 30, 2025
19210707 SYSTEMS AND METHODS FOR AUTOMATICALLY GENERATING A RECORD IN A DIGITAL COMMUNICATION NETWORK Sequelae, Inc. LAGOY, KYRA RAND 3685 Non-Final OA May 16, 2025
19174814 ARTIFICIAL INTELLIGENCE POWERED CHIEF OF STAFF BOT TransforML Platforms Inc. FILIPCZYK, MARCIN R 2153 Non-Final OA Apr 09, 2025
19011787 TRANSMISSION SHAFT BRAKE FOR ENGINE AUTO RESTART Eku Power Drives Inc. AMICK, JACOB M 3747 Non-Final OA Jan 07, 2025
18969246 FOUNDATION POSITION MEASUREMENT USING ALTIMETERS Unknown SHERWIN, RYAN W 2688 Non-Final OA Dec 04, 2024
18821994 SAFETY COLLAR FOR A PRESSURIZED CONTAINER Total Safety U.S., Inc. PANCHOLI, VISHAL J 3754 Non-Final OA Aug 30, 2024
18835285 AUTONOMOUS SYSTEM TRAINING AND TESTING Waabi Innovation Inc. TSWEI, YU-JANG 2614 Non-Final OA Aug 01, 2024
18780957 HIDDEN EDGE FOR FLOORING FINISHING Columbia Insurance Company MAESTRI, PATRICK J 3635 Non-Final OA Jul 23, 2024
18778274 COATING COMPOSITIONS, POLYMERIC COATINGS, AND METHODS Covalon Technologies, Ltd. BOWMAN, ANDREW J 1717 Non-Final OA Jul 19, 2024
18724755 REFRIGERATED PROCESSED FOODS OF EXTENDED DURABILITY AND METHOD FOR THE CONSERVATION THEREOF Coroos Beheer BV LEFF, STEVEN N 1792 Non-Final OA Jun 27, 2024
18754460 Minimally Invasive Carpal Tunnel Release Device and Method Unknown HOAG, MITCHELL BRAIN 3771 Non-Final OA Jun 26, 2024
18742865 METHODS AND COMPOSITIONS FOR ELECTOPHORETIC SEPARATIONS DH TECHNOLOGIES DEVELOPMENT PTE. LTD. NOGUEROLA, ALEXANDER STEPHAN 1795 Non-Final OA Jun 13, 2024
18736525 MULTIMODAL FOUR-DIMENSIONAL PANOPTIC SEGMENTATION Waabi Innovation Inc. OSINSKI, MICHAEL S 2674 Non-Final OA Jun 06, 2024
18736522 AUTOMATIC LABELING OF OBJECTS FROM LIDAR POINT CLOUDS VIA TRAJECTORY-LEVEL REFINEMENT Waabi Innovation Inc. MCCLEARY, CAITLIN RENEE 3669 Non-Final OA Jun 06, 2024
18666728 DEFERRED NEURAL LIGHTING IN AUGMENTED IMAGE GENERATION Waabi Innovation Inc. LI, GRACE Q 2618 Non-Final OA May 16, 2024
18655104 NATURAL GAS ENGINE START AND LOAD SYSTEM Flanders Electric Motor Service, LLC LIETHEN, KURT PHILIP 3747 Final Rejection May 03, 2024
18649142 REACTIONS USING FACILITATORS AND MODERATORS K-Orbital LLC GARNER, LILY CRABTREE 3646 Non-Final OA Apr 29, 2024
18632524 CLAMP FOR SECURING SOLAR PANEL FRAMES TO STRUCTURAL ELEMENTS Bluescope Buildings North America WEINHOLD, INGRID M 3632 Non-Final OA Apr 11, 2024
18695256 ADJUSTABLE/PERSONALISED SEAT ARRANGEMENT AND SYSTEM Unknown CHEN, JOSE V 3637 Non-Final OA Mar 25, 2024
18598279 ANTI-PINCH FOLDABLE TROLLEY Zhejiang Beihuan Outdoor Products Co., Ltd. OLSZEWSKI, JOHN 3617 Non-Final OA Mar 07, 2024
18686618 OPTIMIZATION OF DMS SEPARATIONS USING ACOUSTIC EJECTION MASS SPECTROMETRY (AEMS) DH TECHNOLOGIES DEVELOPMENT PTE. LTD. VANORE, DAVID A 2878 Non-Final OA Feb 26, 2024
18684682 COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY The Akkermansia Company MOREAU, NASHARA LOUISE 1655 Non-Final OA Feb 18, 2024
18683343 DISCRETE PEG MOLECULES AS ANALYTES FOR MS CALIBRATION AND TUNING IN POSITIVE AND NEGATIVE MODES DH TECHNOLOGIES DEVELOPMENT PTE. LTD. GUTIERREZ, GISSELLE M 2884 Non-Final OA Feb 13, 2024
18439838 FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS Ikaria Inc. STEELE, AMBER D 1658 Non-Final OA Feb 13, 2024
18431233 ARTIFICIAL INTELLIGENCE SYSTEM AND METHODS FOR ANIMAL DECISION SUPPORT Whiskers Worldwide, LLC HINCKLEY, CHASE PAUL 2124 Non-Final OA Feb 02, 2024
18292647 POROUS MATERIALS, METHODS AND USES THEREOF National University Of Singapore IMANI, ELIZABETH MARY COLE 1789 Non-Final OA Jan 26, 2024
18291808 LIPID NANOPARTICLE FORMULATIONS Monash University WERTZ, ASHLEE ELIZABETH 1612 Non-Final OA Jan 24, 2024
18577341 MYCOREMEDIATION OF CONTAMINANTS Mycocycle, Inc. MCKNIGHT, CIARA A 1656 Final Rejection Jan 08, 2024
18543767 CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA Alkermes Pharma Ireland Limited RHOADES, DEREK JAMES 1692 Final Rejection Dec 18, 2023
18570745 CRISPR CASCADE The Board Of Trustees Of The University Of Illinois KAPUSHOC, STEPHEN THOMAS 1683 Non-Final OA Dec 15, 2023
18539509 ANTIBODIES AGAINST PD-L1 Genmab A/S ALLEN, MARIANNE P 1647 Final Rejection Dec 14, 2023
18569859 COMPOSITION COMPRISING DRY EXTRACT OF LYOPHILISED INTESTINAL CONTENT OF ADULT CHICKEN, RELATIVE USE AS FOOD SUPPLEMENT AND USE FOR STIMULATING THE IMMUNE SYSTEM Orbiotek Sàrl TURNER, FELICIA C 1793 Non-Final OA Dec 13, 2023
18568747 METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING The Governing Council of the University of Toronto BERTOGLIO, VALARIE E 1632 Non-Final OA Dec 08, 2023
18526352 FORMULATION OF A PAN-JAK INHIBITOR Kinaset Therapeutics, Inc. STEVENS, MARK V 1613 Non-Final OA Dec 01, 2023
18565392 COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND TYPE I PRMT INHIBITOR Glaxosmithkline Intellectual Property (No.4) Limited RODRIGUEZ, RAYNA B 1628 Non-Final OA Nov 29, 2023
18563545 TRANSPLANT MATERIAL AND KIDNEY TRANSPLANT KIT Pormedtec Co., Ltd. BEHARRY, ZANNA MARIA 1632 Non-Final OA Nov 22, 2023
18507340 NEGATIVE PRESSURE DRAINAGE SYSTEM Shenzhen Bao'An People'S Hospital YANG, CHENG FONG 3781 Non-Final OA Nov 13, 2023
18503353 SYSTEM AND METHODS FOR GENOMICS-EHR INTEGRATION Leap Of Faith Technologies, Inc. PATEL, SHERYL GOPAL 3685 Non-Final OA Nov 07, 2023
18501729 COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TYPE II PRMT INHIBITOR Ideaya Biosciences, Inc. HUTTER, GILLIAN A 1625 Final Rejection Nov 03, 2023
18558999 LIPOSOMES DISPLAYING A GLYCAN LIGAND FOR CD33 AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE The Governors of the University of Alberta RONEY, CELESTE A 1612 Non-Final OA Nov 03, 2023
18499357 PROGNOSTIC BIOMARKERS FOR CANCER RELAPSE VACCINATION AND THE USE THEREOF Mendus B.V. JOHANSEN, PETER N. 1644 Non-Final OA Nov 01, 2023
18492635 PROBABILISTIC MULTI-PARTY AUDIO TRANSLATION Mass Luminosity, Inc. MEIS, JON CHRISTOPHER 2654 Final Rejection Oct 23, 2023
18556260 COMPOUNDS Pathios Therapeutics Limited JARRELL, NOBLE E 1699 Non-Final OA Oct 19, 2023
18556218 METHODS OF TREATING ADENOCARCINOMA WITH HUMAN MICROBIOTA DERIVED N-ACYL AMIDES Rockefeller University HSU, GRACE CHING 1627 Non-Final OA Oct 19, 2023
18555058 COMBINATION THERAPY COMPRISING A PKC INHIBITOR AND A MEK INHIBITOR Pfizer, Inc. O DELL, DAVID K 1621 Non-Final OA Oct 12, 2023
18554759 TRI-SUBSTITUTED INDOLE BINDING FUNCTION 3 (BF3) COMPOUNDS AND METHODS FOR THEIR USE Simon Fraser University REDWOOD, CHRISTOPHER EVAN 1629 Non-Final OA Oct 10, 2023
18286072 NOVEL FAMILY OF DNA POLYMERASES ACCEPTING 2-AMINOADENINE AND REJECTING ADENINE IN THEIR SUBSTRATES COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES REGA, KYLE THOMAS 1636 Non-Final OA Oct 06, 2023
18284952 THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING Kymab Limited LEE, YIE CHIA 1642 Non-Final OA Sep 29, 2023
18553271 METHODS OF TREATMENT USING FUROSEMIDE Scpharmaceuticals Inc. SHIM, DAVID M. 1626 Non-Final OA Sep 29, 2023
18284129 METHOD FOR PRODUCING OVARIAN SOMATIC CELL-LIKE CELLS, AND METHOD FOR INDUCING DIFFERENTIATION OF PRIMATE PLURIPOTENT STEM CELLS INTO OVARIAN SOMATIC CELL-LIKE CELLS Kyushu University, National University Corporation ROGERS, ERIC JASON 1638 Non-Final OA Sep 26, 2023
18551618 FUNCTIONAL NUCLEIC ACID MOLECULES DIRECTED TO TARGETS FOR NERVOUS SYSTEM DISORDERS Fondazione Istituto Italiano Di Tecnologia SHEN, WU CHENG WINSTON 1682 Non-Final OA Sep 21, 2023
18283375 BIOLOGICAL SAMPLE PREPARATION AND ANALYSIS DH TECHNOLOGIES DEVELOPMENT PTE. LTD. GABEL, GAILENE 1678 Non-Final OA Sep 21, 2023
18283367 SYSTEMS AND METHODS FOR HUMIDITY AND/OR TEMPERATURE CONTROL IN A SAMPLE ANALYSIS SYSTEM DH TECHNOLOGIES DEVELOPMENT PTE. LTD. NGUYEN, HENRY H 1758 Non-Final OA Sep 21, 2023
18470105 INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF NLRP3 INFLAMMASOME BIOAGE LABS, INC. CHONG, YONG SOO 1623 Non-Final OA Sep 19, 2023
18550807 PROTEINS AND USES THEREOF James Cook University BROWN, DALIYAH MONYHE 1654 Non-Final OA Sep 15, 2023
18548708 CAPILLARY ELECTROPHORESIS METHODS FOR QUANTIFYING VIRAL SPECIES DH TECHNOLOGIES DEVELOPMENT PTE. LTD. SIFFORD, JEFFREY MARK 1671 Non-Final OA Sep 01, 2023
18448283 SOFTWARE FOR MICROFLUIDIC SYSTEMS INTERFACING WITH MASS SPECTROMETRY Intabio, LLC NGHIEM, MICHAEL P 2857 Non-Final OA Aug 11, 2023
17998586 TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN ANTI-PLATELET AGENT. The Heart Research Institute Ltd. PIHONAK, SARAH 1627 Non-Final OA Aug 11, 2023
18276519 METHOD FOR THE PREPARATION OF PYRAZOLE DERIVATIVES AS MODULATORS OF CFTR PROTEIN Fondazione Per La Ricerca Sulla Fibrosi Cistica Ets BELL, SARA ELIZABETH 1625 Non-Final OA Aug 09, 2023
18361156 MODULAR MULTI-PANEL SOLAR CELL 4D Vision Corp. CANNON, RYAN SMITH 1726 Final Rejection Jul 28, 2023
18274605 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES UNIVERSITAET ULM CHANDRA, GYAN 1674 Non-Final OA Jul 27, 2023
18274624 METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES UNIVERSITAET ULM NICKOL, GARY B 1643 Non-Final OA Jul 27, 2023
18273003 NUCLEIC ACID FRAGMENT AND USE THEREOF Kyushu University, National University Corporation HANEY, AMANDA MARIE 1682 Non-Final OA Jul 18, 2023
18040321 TESTING DEVICE WITH BUILT-IN LIQUID STORAGE AusMed Global Limited MUI, CHRISTINE T 1797 Non-Final OA Jul 14, 2023
18271660 MARKER FOR ASSISTING IN DIAGNOSIS OF NEPHROTIC SYNDROME AND USE THEREOF Niigata University NGUYEN, NAM P 1678 Non-Final OA Jul 10, 2023
18271112 MEDIUM FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, METHOD FOR CULTURING AND EXPANDING NEPHRON PROGENITOR CELLS, AND METHOD FOR PRODUCING RENAL ORGANOIDS Rege Nephro Co., Ltd. O'NEILL, MARISOL ANN 1633 Non-Final OA Jul 06, 2023
18342191 SYSTEM AND METHOD FOR FABRICATING EXTENDED LENGTH FLEXIBLE CIRCUITS All Flex Solutions, Inc. TUGBANG, ANTHONY D 2896 Non-Final OA Jun 27, 2023
18259327 POLY-ION COMPLEX MICELLE Kawasaki Institute Of Industrial Promotion SCOTLAND, REBECCA LYNN 1615 Non-Final OA Jun 26, 2023
18268438 METHOD AND SYSTEM FOR TIMED INTRODUCTION OF SAMPLE INTO A MASS SPECTROMETER DH TECHNOLOGIES DEVELOPMENT PTE. LTD. CHANG, HANWAY 2878 Final Rejection Jun 20, 2023
18209609 THREE DIMENSIONAL OBJECT RECONSTRUCTION FOR SENSOR SIMULATION Waabi Innovation Inc. BADER, ROBERT N. 2611 Final Rejection Jun 14, 2023
18267288 ANTI-APRIL ANTIBODIES AND USES THEREOF Université De Lausanne GURLEY, JAMI MICHELLE 1647 Non-Final OA Jun 14, 2023
18255420 PRODUCTION OF FUNGAL BIOMASS Mushlabs GmbH ARIANI, KADE 1651 Non-Final OA Jun 01, 2023
18254915 NEEDLE AND COLLECTION DEVICE FOR OCULAR BIOPSY AND METHODS OF USE Visionaire Products, Inc. HOEKSTRA, JEFFREY GERBEN 3791 Non-Final OA May 30, 2023
18254625 SYSTEM AND METHODS FOR SEGMENTED FLOW ANALYSIS DH TECHNOLOGIES DEVELOPMENT PTE. LTD. MASKELL, MICHAEL P 2878 Non-Final OA May 26, 2023
18039091 NON AGGREGATING MICROFLUIDIC MIXER AND METHODS THEREFOR Global Life Sciences Solutions Canada Ulc INSLER, ELIZABETH 1774 Non-Final OA May 26, 2023
18201620 USE OF ANTI-IL-27 ANTIBODIES Msd International GmbH FAUST, AMBER KATHLEEN 1643 Non-Final OA May 24, 2023
18201626 USE OF ANTI-IL-27 ANTIBODIES F. Hoffmann-La Roche AG JOHNSON, TIRONE DEREK 1675 Non-Final OA May 24, 2023
18197670 USE OF LEUKEMIA-DERIVED CELLS FOR ENHANCING NATURAL KILLER (NK) CELL THERAPY Mendus B.V. LARA, CAROLINE MONSERRAT 1633 Non-Final OA May 15, 2023
18252904 NEAR INFRARED-II PROBES AS HIGH AFFINITY TARGETING IMAGING AGENTS AND USES THEREOF On Target Laboratories, LLC AEDER, SEAN E 1642 Non-Final OA May 15, 2023
18252896 METHOD FOR DETECTING AND/OR QUANTIFYING A METAL ELEMENT IN A BIOLOGICAL LIQUID Cardiovascular Lab S.r.l. GAMBLE JR, RANDALL LEE 1795 Non-Final OA May 15, 2023
18036144 FUSION PROTEIN TARGETING BOTH CD3 AND CD137, PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING IMMUNOAH PHARMATECH CO., LTD. MOSELEY II, NELSON B 1642 Non-Final OA May 09, 2023
18251493 A PROCESS FOR PRODUCING EGF Chemical & Biopharmaceutical Laboratories Of Patras S.A. DABKOWSKI, ERINNE R 1654 Non-Final OA May 02, 2023
18307559 TREATMENT OF POLYCYSTIC DISEASES WITH AN HDAC6 INHIBITOR Mayo Foundation for Medical Education and Research LEE, WILLIAM Y 1623 Non-Final OA Apr 26, 2023
18033009 ENGINEERED Cas12f PROTEIN The University of Tokyo HUDSON, AMY ROSE 1636 Non-Final OA Apr 20, 2023
18303533 SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS Massachusetts Institute Of Technology GROOMS, TIFFANY NICOLE 1637 Non-Final OA Apr 19, 2023
18303346 COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS Als Therapy Development Institute SABILA, MERCY HELLEN 1654 Final Rejection Apr 19, 2023
18301732 GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS Massachusetts Institute Of Technology ALLEN, SARAH ELIZABETH 1637 Non-Final OA Apr 17, 2023
18031748 USE OF COMBINED ORAL CONTRACEPTIVES CONTAINING NOMEGESTROL ACETATE AND ESTRADIOL Theramex Hq UK Limited HUI, SAN MING R 1627 Final Rejection Apr 13, 2023
18299304 THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY University Of Sydney CRAIG, KAILA ANGELIQUE 1618 Non-Final OA Apr 12, 2023
18299346 ARTIFICIAL INTELLIGENCE MENTAL HEALTH DIAGNOSTIC SYSTEM AND METHOD Ben Prince EDOUARD, PATRICIA KELLY 3681 Non-Final OA Apr 12, 2023
18193958 METHODS OF TREATING ENHANCING BRAIN TUMORS USING COMBINATION THERAPY Servier Pharmaceuticals Llc. TRAN HO, LAM THUY VI 1647 Non-Final OA Mar 31, 2023
18029725 SIRT1 INHIBITOR OR ANTAGONIST FOR USE IN PREVENTING AND/OR TREATING AN HPV INDUCED TUMOUR UNIVERSITA' DEGLI STUDI DEL PIEMONTE ORIENTALE "A. AVOGADRO" GIBBS, TERRA C 1635 Final Rejection Mar 31, 2023
18028702 ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS SPECIFICALLY BINDING TO GREMLIN-1 AND USES THEREOF Kantonsspital St. Gallen HADDAD, MAHER M 1641 Non-Final OA Mar 27, 2023
18188045 GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR Anagenix IP Limited BARHAM, BETHANY P 1611 Non-Final OA Mar 22, 2023
18245902 MODIFIED FUNCTIONAL NUCLEIC ACID MOLECULES Transine Therapeutics Limited DAUNER, JOSEPH G 1682 Non-Final OA Mar 20, 2023
18027306 METHOD FOR PREPARING EFFECTOR CELLS WITH DESIRED SPECIFICITY National University Corporation Shiga University Of Medical Science ZHU, JIANJIAN 1631 Non-Final OA Mar 20, 2023
18183257 Pharmaceutical Compositions Comprising Sorbitan Esters Alkermes Pharma Ireland Limited ALLEY, GENEVIEVE S 1617 Final Rejection Mar 14, 2023
18245072 DETECTION OF CIRCULATING TUMOR CELLS USING TUMOR-TARGETED NIR AGENTS On Target Laboratories, LLC MARCSISIN, ELLEN JEAN 1677 Non-Final OA Mar 13, 2023
18025503 METHOD FOR PRODUCING CENTRE FILLED GUMMIES COMPRISING FILLINGS Rousselot BV KIM, DANIELLE A 1613 Non-Final OA Mar 09, 2023
18119487 MODIFIED CELLS OF LEUKEMIC ORIGIN AND A PD-L1 ANTIBODY FOR ENHANCING THE EFFICACY OF CANCER CELL THERAPY Mendus B.V. BUTTICE, AUDREY L 1647 Non-Final OA Mar 09, 2023
18023107 RAPID, ACCURATE, SCALABLE AND PORTABLE TESTING (SPOT) SYSTEM The Board Of Trustees Of The University Of Illinois SWITZER, JULIET CAROLINE 1682 Non-Final OA Feb 24, 2023
18108961 PROTEINS BINDING NKG2D, CD16 AND NECTIN4 Dragonfly Therapeutics, Inc. BRISTOL, LYNN ANNE 1643 Final Rejection Feb 13, 2023
18041192 Method for Extracting cIEF-MS Profiles from m/z versus Time Arrays DH TECHNOLOGIES DEVELOPMENT PTE. LTD. ISLAM, MOHAMMAD K 2857 Final Rejection Feb 09, 2023
18040171 METHODS OF TREATMENT USING FUROSEMIDE Scpharmaceuticals Inc. CORNET, JEAN P 1628 Non-Final OA Feb 01, 2023
18004671 MICROFLUIDIC CELL CULTURE DEVICE Mimetas B.V. GERHARD, ALISON CLAIRE 1797 Non-Final OA Jan 07, 2023
18004386 COMPOUNDS AS MODULATORS OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (ERAP1) Grey Wolf Therapeutics Limited BARSKY, JARED 1628 Final Rejection Jan 05, 2023
18003974 AMUC-1100 POLYPEPTIDE VARIANTS FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS Compagnie Gervais Danone GRASER, JENNIFER E 1645 Final Rejection Dec 30, 2022
18091651 DEVICES AND METHODS FOR SAMPLE CHARACTERIZATION Intabio, LLC CHIU, TAK LIANG 1777 Final Rejection Dec 30, 2022
18013440 PROCESS FOR THE PREPARATION OF IOPAMIDOL GE Healthcare AS BONAPARTE, AMY C 1692 Final Rejection Dec 28, 2022
18009498 ISOTHERMAL REAL-TIME PCR METHOD FOR DETERMINING PRESENCE OF A PRE-DETERMINED NUCLEIC ACID SEQUENCE IN ANIMAL SAMPLES Ender Holding AG HOPPE, EMMA RUTH 1683 Non-Final OA Dec 09, 2022
18062311 CENTRIFUGE APHERETIC SYSTEM Astrin Biosciences, Inc. KASS, BENJAMIN JOSEPH 1798 Non-Final OA Dec 06, 2022
17926757 NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF UNIVERSITAET ZUERICH THUESON, HANNA MARIE 1638 Final Rejection Nov 21, 2022
17999330 COMPOSITION FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA Unknown SHUPE, ELIZABETH A 1643 Non-Final OA Nov 18, 2022
17999008 N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65 Pathios Therapeutics Limited MOORE, SUSANNA 1624 Final Rejection Nov 16, 2022
17999001 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited BAUER, NICOLA MARIA 1621 Non-Final OA Nov 16, 2022
17998587 VIRAL VECTORS EXPRESSING THERAPEUTIC PROTEINS SPECIFICALLY IN MYELOID CELLS AND MICROGLIA UNIVERSITAET ZUERICH PRONZATI, GINA 1633 Non-Final OA Nov 11, 2022
17998574 POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD Nutcracker Therapeutics, Inc. DENT, ALANA HARRIS 1643 Non-Final OA Nov 11, 2022
17997602 A RADAR SYSTEM HAVING A PHOTONICS-BASED SIGNAL GENERATOR The University of Sydney MAGLOIRE, VLADIMIR 3648 Final Rejection Oct 31, 2022
17920881 MICROFLUIDIC DEVICES WITH GAS CHANNELS FOR SAMPLE NEBULIZATION Intabio, LLC TANDY, LAURA ELOISE 2881 Final Rejection Oct 24, 2022
17996126 LONG ACTING GLUCAGON RECEPTOR SELECTIVE PEPTIDES AND METHODS OF USE I2O Therapeutics, Inc. KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Non-Final OA Oct 13, 2022
17937778 RADIATION SENSITIVITY ENHANCING COMOPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT Korea Institute Of Radiological & Medical Sciences THOMAS, TIMOTHY P 1614 Non-Final OA Oct 03, 2022
17915361 MEDICAMENT FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME OR INFLAMMATORY BOWEL DISEASE Nippon Chemiphar Co., Ltd. CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Sep 28, 2022
17909036 METHOD FOR QUANTIFYING ADIPONECTIN AND ANALYTICAL REAGENT USED THEREOF Tatsuya Sawamura BORGEEST, CHRISTINA M 1675 Final Rejection Sep 02, 2022
17760413 METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCTS FOR MANAGEMENT OF SUPPLY CHAINS AND/OR INVENTORY FOR PERISHABLE GOODS Freshpoint Quality Assurance Ltd. DELIGI, VANESSA LIMA 3627 Non-Final OA Aug 09, 2022
17798415 CHONDROITINASE ABC MUTANTS AND METHODS OF MANUFACTURE AND USE THEREOF Yeda Research And Development Co. Ltd. RAGHU, GANAPATHIRAM 1652 Final Rejection Aug 09, 2022
17760329 USP7 INHIBITOR FOR USE IN THE TREATMENT OF CANCER Almac Discovery Limited REILLY, SOPHIA JANE 1627 Non-Final OA Aug 08, 2022
17817033 MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 BIONTECH SE KAUFMAN, CLAIRE M 1674 Non-Final OA Aug 03, 2022
17792084 CAPILLARY ELECTROPHORESIS METHODS FOR VIRAL VECTOR SEPARATION, ANALYSIS, CHARACTERIZATION AND QUANTIFICATION DH TECHNOLOGIES DEVELOPMENT PTE. LTD. KUMAR, SRILAKSHMI K 1700 Final Rejection Jul 11, 2022
17787545 NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES GE Healthcare AS ROGERS, JAMES WILLIAM 1618 Non-Final OA Jun 20, 2022
17785011 ANTI-SERUM ALBUMIN ANTIBODIES Cullinan Therapeutics, Inc. ALLEN, MICHAEL D 1671 Final Rejection Jun 13, 2022
17781554 ANTI-SLC6A1 OLIGONUCLEOTIDES AND RELATED METHODS UNIVERSITY OF MASSACHUSETTS CHONG, KIMBERLY 1636 Final Rejection Jun 01, 2022
17778902 SOFTWARE FOR MICROFLUIDIC SYSTEMS INTERFACING WITH MASS SPECTROMETRY Intabio, LLC DESTA, ELIAS 2857 Non-Final OA May 23, 2022
17756095 DOSING REGIMENS FOR A PROTEIN KINASE C INHIBITOR Ideaya Biosciences, Inc. LEE, WILLIAM Y 1623 Non-Final OA May 17, 2022
17775864 O-GLCNACYLATED PROTEIN-LIKE SUBSTANCE AND FIBROSIS THERAPEUTIC DRUG CONTAINING SAME Somar Corporation CRAIGO, BAHAR ALAWI 1699 Final Rejection May 10, 2022
17728336 RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS VICO Therapeutics B.V. CHONG, KIMBERLY 1636 Final Rejection Apr 25, 2022
17769657 METHOD FOR PRODUCING RADIOACTIVE METAL-LABELED ANTIBODY Nihon Medi-Physics Co., Ltd. JONES, DAMERON LEVEST 1618 Non-Final OA Apr 15, 2022
17704915 OLIGONUCLEOTIDES FOR SYNGR-3 MODULATION UNIVERSITY OF MASSACHUSETTS VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Mar 25, 2022
17701888 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. MOU, LIYUAN 1628 Non-Final OA Mar 23, 2022
17636476 APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDE Hunan Warrant Pharmaceutical Technology Development Co., Ltd. ISMAIL, REHANA 1625 Non-Final OA Feb 18, 2022
17650298 METHOD OF TREATING CANCER WITH NUCLEOTIDE THERAPEUTICS The General Hospital Corporation LEE, HOI YAN NMN 1693 Final Rejection Feb 08, 2022
17625433 FUNCTIONAL NUCLEIC ACID MOLECULES UPREGULATING THE TRANSLATION OF A FRATAXIN MRNA Scuola Internazionale Superiore Studi Internazionale Superiore Di Studi Avanzati - Sissa RAVINDRA, KRISHNA NUGGEHALLI 1636 Non-Final OA Jan 07, 2022
17619837 STABLE COLLOIDAL DRUG AGGREGATES AND METHODS OF MANUFACTURE AND USE THEREOF The Regents of the University of California OLSEN, KAELEIGH ELIZABETH 1619 Final Rejection Dec 16, 2021
17532636 OLIGONUCLEOTIDES FOR DGAT2 MODULATION UNIVERSITY OF MASSACHUSETTS ARIETI, RUTH SOPHIA 1635 Final Rejection Nov 22, 2021
17495213 METHOD FOR IDENTIFICATION OF CANCER PATIENTS WITH DURABLE BENEFIT FROM IMMUNOTEHRAPY IN OVERALL POOR PROGNOSIS SUBGROUPS BIODESIX, INC. BICKHAM, DAWN MARIE 1685 Non-Final OA Oct 06, 2021
17466516 USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS Wageningen Universiteit GOUGH, TIFFANY MAUREEN 1651 Non-Final OA Sep 03, 2021
17262400 METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL National University Corporation Shiga University Of Medical Science MIANO, JOSEPH PAUL 1631 Non-Final OA Aug 27, 2021
17391475 OLIGONUCLEOTIDES FOR HTT-1A MODULATION UNIVERSITY OF MASSACHUSETTS VYAS, KEYUR ANILKUMAR 1637 Non-Final OA Aug 02, 2021
17293671 THIOAMIDE-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF Noria Therapeutics, Inc. ELENISTE, PIERRE PAUL 1622 Non-Final OA May 13, 2021
17318846 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING UNIVERSITY OF MASSACHUSETTS ZARA, JANE J 1637 Non-Final OA May 12, 2021
17313369 Biological Fluid Filtration System Astrin Biosciences, Inc. LYLE, SOPHIA YUAN 1796 Final Rejection May 06, 2021
17313421 Biological Fluid Filtration System Astrin Biosciences, Inc. LYLE, SOPHIA YUAN 1796 Non-Final OA May 06, 2021
17235153 OLIGONUCLEOTIDES FOR MSH3 MODULATION UNIVERSITY OF MASSACHUSETTS VYAS, KEYUR ANILKUMAR 1637 Final Rejection Apr 20, 2021
17162450 Biological Fluid Filtration System Astrin Biosciences, Inc. LYLE, SOPHIA YUAN 1796 Final Rejection Jan 29, 2021
17105789 SPINAL CORD INJURY TREATMENT NEUROSPHERE Keio University WANG, CHANG YU 1675 Final Rejection Nov 27, 2020
17050462 RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT Korea Institute Of Radiological & Medical Sciences THOMAS, TIMOTHY P 1614 Final Rejection Oct 26, 2020
16998587 TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE On Target Laboratories, LLC SCHLIENTZ, LEAH H 1618 Final Rejection Aug 20, 2020
16833107 OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72 UNIVERSITY OF MASSACHUSETTS SHIN, DANA H 1635 Final Rejection Mar 27, 2020
16818563 OLIGONUCLEOTIDES FOR TISSUE SPECIFIC APOE MODULATION UNIVERSITY OF MASSACHUSETTS POLIAKOVA-GEORGAN, EKATERINA 1637 Final Rejection Mar 13, 2020
15555811 MICROPARTICLES Spheritech Ltd. LOVE, TREVOR M 1611 Final Rejection Sep 05, 2017
14112731 CROSS-LINKED POLY-E-LYSINE PARTICLES Spheritech Ltd. MOSS, NATALIE M 1653 Final Rejection Jan 23, 2014

Managing Lathrop Gpm LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month